Modulation of Osteogenic Differentiation by CYBB in Osteoporotic Models
IUBMB Life · 2025
DOI: 10.1002/iub.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Zhaodong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Osteogenesis, Cell Differentiation, Mesenchymal Stem Cells, Osteoporosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Anhui Province Key Laboratory of Tissue Transplantation of Bengbu Medical University, Medical Innovation Foundation from Spinal deformity clinical and research center of Anhui province, Anhui Provincial Department of Education Key Project.
Abstract (Originalsprache)
Osteoporosis (OP) is a prevalent systemic skeletal disease characterized by increased bone fragility and fracture risk. Identifying factors that influence osteogenic differentiation in OP is crucial. We screened genes associated with OP from the Gene Expression Omnibus (GEO) database and constructed a weighted correlation network analysis (WGCNA) to identify hub genes, validating our findings in external and clinical cohorts. Various experiments assessed the proliferation, apoptosis, and osteogenic differentiation abilities of bone marrow mesenchymal stem cells (BMSCs) following CYBB knockdown. We established a postmenopausal OP model in rats through bilateral ovariectomy (OVX) and evaluated OP severity using three‐dimensional computed tomography (3D‐CT) and H&E staining. Differential gene expression analysis revealed that CYBB was significantly upregulated in OP, with the highest area under the curve (AUC) among differentially expressed genes (DEGs). Notably, CYBB expression in BMSCs decreased over time. Knockdown of CYBB promoted BMSC proliferation and reduced apoptosis, as demonstrated by Alizarin red and ALP staining, which indicated enhanced osteogenic differentiation. Markers such as RUNX1, RUNX2, ALP, secreted phosphoprotein 1 (SPP1), and bone sialoprotein (BSP) were upregulated post‐knockdown. In vivo, CYBB knockdown improved bone mineral density (BMD), relative bone volume fraction (BV/TV), and trabecular number (Tb.N). In conclusion, CYBB influences OP progression by modulating bone formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
- Department of Orthopedics, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
- Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical University, Bengbu, Anhui, China.
ORCID-Profile: Jianzhong Guan
Förderung
- Anhui Province Key Laboratory of Tissue Transplantation of Bengbu Medical University
- Medical Innovation Foundation from Spinal deformity clinical and research center of Anhui province
- Anhui Provincial Department of Education Key Project
Zitieren
APA
Wang, Z., Xu, C., Liu, Y., Duan, K., Zhu, Z., & Guan, J. (2025). Modulation of Osteogenic Differentiation by CYBB in Osteoporotic Models. IUBMB Life. https://doi.org/10.1002/iub.70023
Vancouver
Wang Z, Xu C, Liu Y, Duan K, Zhu Z, Guan J. Modulation of Osteogenic Differentiation by CYBB in Osteoporotic Models. IUBMB Life. 2025. doi:10.1002/iub.70023
BibTeX
@article{Wang2025,
author = {Wang, Zhaodong and Xu, Chen and Liu, Yajun and Duan, Keyou and Zhu, Zhonglian and Guan, Jianzhong},
title = {Modulation of Osteogenic Differentiation by CYBB in Osteoporotic Models},
journal = {IUBMB Life},
year = {2025},
doi = {10.1002/iub.70023}
}
EUVIMED